In a major step forward in the fight against HIV/AIDS, the US Food and Drug Administration (FDA) has approved Lenacapavir, an ...

MSD's new drug combination shows promise in HIV-1 treatment, aiming to offset potential losses from Keytruda's patent ...

Discover how breakthrough long-acting HIV medications could transform lives, why Medicaid isn't keeping up, and what needs to change to make treatment ...

I said: 'What's HIV? What's that?'" His test came back positive. Tenoria began treatment. When his health stabilized, he was ...

Gilead stock rated buy for thriving HIV biz, promising oncology pipeline, and long-term growth potential despite volatility.

As we mark the holidays, here are a few of the many heroes who are working to build a stronger global health future by ...

However, the combination of Merck's approved doravirine and investigational islatravir didn't prove superiority over Gilead's ...

ART and PrEP have revolutionized HIV treatment and prevention Latent HIV reservoirs challenge the pursuit of a cure HIV research has influenced treatments for COVID-19 and cancer The Discovery of ...

Uganda is registering around 38,000 new infections despite the deployment of different interventions such as condoms and oral ...

Organized in response to the growing regional challenges of rising HIV infections, gaps in prevention and treatment, and ...

The Deputy Ashanti Regional Focal Person on HIV/AIDs, Dennis Bandoh, has advised men to take the HIV tests as is being done ...

RAHIM YAR KHAN: Another HIV positive patient of the surgical ward of the Shaikh Zayed Medical College Hospital (SZMCH) was ...